Jin‐Xue He

933 total citations
28 papers, 619 citations indexed

About

Jin‐Xue He is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Jin‐Xue He has authored 28 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Oncology and 7 papers in Electrical and Electronic Engineering. Recurrent topics in Jin‐Xue He's work include PARP inhibition in cancer therapy (13 papers), DNA Repair Mechanisms (8 papers) and Ubiquitin and proteasome pathways (8 papers). Jin‐Xue He is often cited by papers focused on PARP inhibition in cancer therapy (13 papers), DNA Repair Mechanisms (8 papers) and Ubiquitin and proteasome pathways (8 papers). Jin‐Xue He collaborates with scholars based in China, United States and South Korea. Jin‐Xue He's co-authors include Yuxin Yin, Wen Shen, Ze‐Hong Miao, Xi Kang, Chunhao Yang, K. Chao, Tingting Gu, Jingyi Yang, Xia‐Juan Huan and Ao Zhang and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Jin‐Xue He

26 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Xue He China 15 477 278 76 64 55 28 619
Daniele Conti Italy 9 341 0.7× 280 1.0× 71 0.9× 68 1.1× 49 0.9× 13 597
Dali Zong United States 17 748 1.6× 318 1.1× 41 0.5× 167 2.6× 20 0.4× 27 873
Haruki Ogata Japan 9 651 1.4× 218 0.8× 64 0.8× 96 1.5× 12 0.2× 21 871
Annalisa Susanna Dorio Italy 13 334 0.7× 311 1.1× 22 0.3× 34 0.5× 32 0.6× 17 497
Xin‐Zhe Li China 6 356 0.7× 95 0.3× 37 0.5× 95 1.5× 12 0.2× 8 486
Marcel Horký Czechia 13 350 0.7× 292 1.1× 101 1.3× 62 1.0× 13 0.2× 19 597
Joe Jiang Zhu Australia 17 285 0.6× 264 0.9× 23 0.3× 85 1.3× 13 0.2× 31 632
Daniele Simoneschi United States 8 514 1.1× 145 0.5× 122 1.6× 61 1.0× 8 0.1× 11 730
Karin Schelch Austria 14 372 0.8× 226 0.8× 34 0.4× 97 1.5× 6 0.1× 39 737
Kathrin Michel Germany 9 196 0.4× 84 0.3× 30 0.4× 38 0.6× 16 0.3× 11 360

Countries citing papers authored by Jin‐Xue He

Since Specialization
Citations

This map shows the geographic impact of Jin‐Xue He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Xue He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Xue He more than expected).

Fields of papers citing papers by Jin‐Xue He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Xue He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Xue He. The network helps show where Jin‐Xue He may publish in the future.

Co-authorship network of co-authors of Jin‐Xue He

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Xue He. A scholar is included among the top collaborators of Jin‐Xue He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Xue He. Jin‐Xue He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Junjie, Ruiyi Ren, Shanshan Song, et al.. (2025). Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors. Journal of Medicinal Chemistry. 68(3). 3673–3699. 2 indexed citations
2.
He, Jin‐Xue, Ben Wang, Aijing Ma, et al.. (2025). Low-viscosity poly-α-olefin production from Fischer-Tropsch mixed α-olefins: Synthesis and kinetics. Fuel. 386. 134322–134322. 2 indexed citations
3.
Song, Shanshan, Xia‐Juan Huan, Xubin Bao, et al.. (2025). USP7 V517F mutation as a mechanism of inhibitor resistance. Nature Communications. 16(1). 2526–2526.
4.
Zhuang, Zhen, Shanshan Song, Xiaofei Zhang, et al.. (2024). Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy. European Journal of Medicinal Chemistry. 277. 116752–116752. 6 indexed citations
5.
Zhuang, Zhen, et al.. (2024). Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy. Biochemical Pharmacology. 222. 116071–116071. 8 indexed citations
6.
Sun, Yuting, Jiaqi Yuan, Shanshan Song, et al.. (2023). YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors. Journal of Medicinal Chemistry. 66(17). 12284–12303. 8 indexed citations
7.
Wang, Pingyuan, Yajing Wang, Shanshan Song, et al.. (2023). Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities. European Journal of Medicinal Chemistry. 259. 115709–115709. 7 indexed citations
8.
Song, Shanshan, Chunyong Ding, Ruihan Zhang, et al.. (2022). Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone. European Journal of Medicinal Chemistry. 240. 114574–114574. 16 indexed citations
9.
Zhou, Lina, Shanshan Song, Xubin Bao, et al.. (2022). SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy. Neoplasia. 32. 100823–100823. 10 indexed citations
10.
Li, Mengzhu, Tao Meng, Shanshan Song, et al.. (2021). Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers. Investigational New Drugs. 39(5). 1213–1221. 7 indexed citations
11.
Zhang, Ning, Lina Zhou, Mengzhu Li, et al.. (2021). Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer. Cell Death and Disease. 12(2). 183–183. 22 indexed citations
12.
Yang, Zhongmin, Xuemei Liao, Yi Chen, et al.. (2017). Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors. Acta Pharmacologica Sinica. 38(7). 1038–1047. 27 indexed citations
13.
Zhang, Zhong, Shengqi Hou, Jin‐Xue He, et al.. (2016). PTEN regulates PLK1 and controls chromosomal stability during cell division. Cell Cycle. 15(18). 2476–2485. 30 indexed citations
14.
He, Jin‐Xue, Zhong Zhang, Fan Yang, et al.. (2016). PTEN regulates EG5 to control spindle architecture and chromosome congression during mitosis. Nature Communications. 7(1). 12355–12355. 41 indexed citations
15.
He, Jin‐Xue, Xi Kang, Yuxin Yin, K. Chao, & Wen Shen. (2015). PTEN regulates DNA replication progression and stalled fork recovery. Nature Communications. 6(1). 7620–7620. 70 indexed citations
16.
Kang, Xi, Chang Ho Song, Cong Zhang, et al.. (2015). PTEN stabilizes TOP2A and regulates the DNA decatenation. Scientific Reports. 5(1). 17873–17873. 36 indexed citations
17.
Chen, Zhe, Minglu Zhu, Jingyi Yang, et al.. (2014). PTEN Interacts with Histone H1 and Controls Chromatin Condensation. Cell Reports. 8(6). 2003–2014. 79 indexed citations
18.
Sun, Zhuo, Jin‐Xue He, Xi Kang, et al.. (2014). PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development. Cell Reports. 6(5). 844–854. 62 indexed citations
19.
He, Jin‐Xue, et al.. (2014). Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(12). 2669–2673. 26 indexed citations
20.
Chen, Dan-Qi, Xin Wang, Lin Chen, et al.. (2011). Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization. Acta Pharmacologica Sinica. 32(5). 664–672. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniele Conti Breakdown of academic impact, for papers by Dali Zong Breakdown of academic impact, for papers by Haruki Ogata Breakdown of academic impact, for papers by Annalisa Susanna Dorio Breakdown of academic impact, for papers by Xin‐Zhe Li Breakdown of academic impact, for papers by Marcel Horký Breakdown of academic impact, for papers by Joe Jiang Zhu Breakdown of academic impact, for papers by Daniele Simoneschi Breakdown of academic impact, for papers by Karin Schelch Breakdown of academic impact, for papers by Kathrin Michel
Rankless by CCL
2026